Tobias Else
-
- Hormonal Regulation and Hypertension 41
- Pituitary Gland Disorders and Treatments 29
- Adrenal Hormones and Disorders 15
- Cancer Research top 0.5%
- Cancer, Hypoxia, and Metabolism 51
- Surgery top 0.5%
- Adrenal and Paraganglionic Tumors 63
- Genetics top 1%
- Glioma Diagnosis and Treatment 15
- Neurology top 5%
-
- Renal cell carcinoma treatment 13
-
- Renal and related cancers 13
- Co-authors
- Gary D. HammerThomas J. GiordanoBarbra S. MillerShruti JollyWilliam E. RaineyVictoria M. RaymondAaron SabolchAlex C. Kim
- Journals
- The Journal of Clinical Endocrinology & Metabolism (18 papers)Journal of Clinical Oncology (11 papers)Hormones and Cancer (6 papers)
- Partner nations
- United StatesDenmarkFrance
In The Last Decade
Tobias Else
123 papers receiving 4.8k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Endocrinology, Diabetes and Metabolism 2.5k
- Cancer Research 2.2k
- Surgery 3.2k
- Genetics 726
- Neurology 306
Countries citing papers authored by Tobias Else
This map shows the geographic impact of Tobias Else's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tobias Else with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tobias Else more than expected).
Fields of papers citing papers by Tobias Else
This network shows the impact of papers produced by Tobias Else. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tobias Else. The network helps show where Tobias Else may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tobias Else, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 11 | |
| 4 | 2024 | 5 | |
| 5 | 2024 | 12 | |
| 6 | 2024 | 16 | |
| 7 | 2024 | 5 | |
| 8 | 2023 | 1 | |
| 9 | 2022 | 4 | |
| 10 | 2022 | 1 | |
| 11 | Oral HIF-2α inhibitor belzutifan for ocular von Hippel-Lindau (VHL) disease | 2021 | 4 |
| 12 | 2021 | 9 | |
| 13 | 2021 | 5 | |
| 14 | 2020 | 18 | |
| 15 | 2020 | 13 | |
| 16 | 2020 | 9 | |
| 17 | 2019 | 46 | |
| 18 | 2017 | 126 | |
| 19 | 2009 | 292 | |
| 20 | 2007 | 26 |
About Tobias Else
Tobias Else is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research and Surgery, having authored 135 papers that have together received 4.9k indexed citations. Recurring topics across this work include Adrenal and Paraganglionic Tumors (63 papers), Cancer, Hypoxia, and Metabolism (51 papers), Hormonal Regulation and Hypertension (41 papers), Pituitary Gland Disorders and Treatments (29 papers), Glioma Diagnosis and Treatment (15 papers), Adrenal Hormones and Disorders (15 papers), Renal cell carcinoma treatment (13 papers) and Renal and related cancers (13 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.5k citations), Cancer Research (2.2k citations) and Surgery (3.2k citations). Tobias Else has collaborated with scholars based in United States, Denmark and France. Frequent co-authors include Gary D. Hammer, Thomas J. Giordano, Barbra S. Miller, Shruti Jolly, William E. Rainey, Victoria M. Raymond, Aaron Sabolch, Alex C. Kim, Elaine M. Caoili and Kazutaka Nanba. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, Journal of Clinical Oncology, Hormones and Cancer, European Journal of Endocrinology and Experimental and Clinical Endocrinology & Diabetes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.